<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">31054</article-id><article-id pub-id-type="doi">10.7554/eLife.31054</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Anti-diabetic drug binding site in a mammalian K<sub>ATP</sub> channels revealed by Cryo-EM</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-77319"><name><surname>Martin</surname><given-names>Gregory M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-95172"><name><surname>Kandasamy</surname><given-names>Balamurugan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-82482"><name><surname>DiMaio</surname><given-names>Frank</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7524-8938</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-77320"><name><surname>Yoshioka</surname><given-names>Craig</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-76853"><name><surname>Shyng</surname><given-names>Show-Ling</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8230-8820</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution>, <institution>Oregon Health and Science University</institution>, <addr-line><named-content content-type="city">Portland</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Washington</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Biomedical Engineering</institution>, <institution>Oregon Health and Science University</institution>, <addr-line><named-content content-type="city">Portland</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5115"><name><surname>Swartz</surname><given-names>Kenton J</given-names></name><role>Reviewing editor</role><aff><institution>National Institutes of Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>yoshiokc@ohsu.edu</email> (CY);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>shyngs@ohsu.edu</email> (SS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>10</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e31054</elocation-id><history><date date-type="received"><day>05</day><month>08</month><year>2017</year></date><date date-type="accepted"><day>11</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Martin et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Martin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-31054-v1.pdf"/><abstract><p>Sulfonylureas are anti-diabetic medications that act by inhibiting pancreatic K<sub>ATP</sub> channels composed of SUR1 and Kir6.2. The mechanism by which these drugs interact with and inhibit the channel has been extensively investigated, yet it remains unclear where the drug binding pocket resides. Here, we present a cryo-EM structure of a hamster SUR1/rat Kir6.2 channel bound to a high-affinity sulfonylurea drug glibenclamide and ATP at 3.63Å resolution, which reveals unprecedented details of the ATP and glibenclamide binding sites. Importantly, the structure shows for the first time that glibenclamide is lodged in the transmembrane bundle of the SUR1-ABC core connected to the first nucleotide binding domain near the inner leaflet of the lipid bilayer. Mutation of residues predicted to interact with glibenclamide in our model led to reduced sensitivity to glibenclamide. Our structure provides novel mechanistic insights of how sulfonylureas and ATP interact with the K<sub>ATP</sub> channel complex to inhibit channel activity.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Rat</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK066485</award-id><principal-award-recipient><name><surname>Shyng</surname><given-names>Show-Ling</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>F31DK105800</award-id><principal-award-recipient><name><surname>Martin</surname><given-names>Gregory M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="EMD-7073" source-id-type="uri"><collab>Show-Ling Shyng</collab>, <collab>Craig Yoshioka</collab>, <collab>Gregory Martin</collab>, <year>2017</year><x>,</x> <source>Cryo-EM structure of the pancreatic beta-cell KATP channel bound to ATP and glibenclamide</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="EMD-7073">EMD-7073</ext-link><x>,</x> <comment>Publicly available at RCSB Protein Data Bank (http://www.rcsb.org).</comment></related-object><related-object content-type="generated-dataset" id="dataro2" source-id="PDB-6BAA" source-id-type="uri"><collab>Show-Ling Shyng</collab>, <collab>Craig Yoshioka</collab>, <collab>Gregory Martin</collab>, <year>2017</year><x>,</x> <source>Cryo-EM structure of the pancreatic beta-cell KATP channel bound to ATP and glibenclamide</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="PDB-6BAA">PDB-6BAA</ext-link><x>,</x> <comment>Publicly available at RCSB Protein Data Bank (http://www.rcsb.org).</comment></related-object></p><p>The following previously published datasets were used:</p><p><related-object content-type="generated-dataset" id="dataro3" source-id="https://www.rcsb.org/pdb/explore/explore.do?structureId=5TWV" source-id-type="uri"><collab>GM Martin</collab>, <collab>C Yoshioka</collab>, <collab>EA Rex</collab>, <collab>JF Fay</collab>, <collab>Q Xie</collab>, <collab>MR Whorton</collab>, <collab>JZ Chen</collab>, <collab>S-L Shyng</collab>, <year>2017</year><x>,</x> <source>Cryo-EM structure of the pancreatic ATP-sensitive K+ channel SUR1/Kir6.2 in the presence of ATP and glibenclamide</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/pdb/explore/explore.do?structureId=5TWV">https://www.rcsb.org/pdb/explore/explore.do?structureId=5TWV</ext-link><x>,</x> <comment>PDB ID:5TWV</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-31054-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>